🇺🇸 FDA
Patent

US 6177415

Bacteriohopanetetrol and related compounds useful for modulation of lipoxygenase activity and anti-inflammatory applications

expired A61KA61K31/56A61K31/58

Quick answer

US patent 6177415 (Bacteriohopanetetrol and related compounds useful for modulation of lipoxygenase activity and anti-inflammatory applications) held by The United States of America, as represented by the Secretary of Agriculture expires Mon Jan 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Secretary of Agriculture
Grant date
Tue Jan 23 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/56, A61K31/58